|
About the Limits of Nitrosamines category
|
|
0
|
786
|
April 14, 2021
|
|
N-Nitroso mirabegron
|
|
4
|
2081
|
August 2, 2023
|
|
Nitrosamine impurities of related substances of API's
|
|
5
|
363
|
July 11, 2024
|
|
EMA - Appendix 1 - Update
|
|
12
|
1375
|
July 10, 2024
|
|
Nitrosamine Acceptable Intake Limits
|
|
2
|
246
|
July 10, 2024
|
|
🇨🇦 Health Canada updated the guidance and Appendix 1(May 31, 2024)
|
|
16
|
1521
|
July 10, 2024
|
|
Control limit of Nitrosamines and N-nitroso compounds
|
|
2
|
285
|
July 8, 2024
|
|
Nitroso lisinopril
|
|
3
|
296
|
July 4, 2024
|
|
Nitroso Dimethyl anthranilate
|
|
7
|
274
|
June 29, 2024
|
|
N-nitroso Solifenacin
|
|
7
|
250
|
June 28, 2024
|
|
MEGLUMINE (Methylglucamine)
|
|
18
|
2306
|
June 19, 2024
|
|
Tetrazole nitrosamines
|
|
1
|
206
|
June 13, 2024
|
|
N-Nitroso Hydrochlorothiazide in Hydrochlorothiazide drug substance
|
|
12
|
3828
|
June 11, 2024
|
|
Limit for API having two NDSRI
|
|
14
|
1907
|
June 11, 2024
|
|
Lhasa TD50 or Gold TD50 to set AI limit?
|
|
8
|
526
|
June 10, 2024
|
|
CPCA Category 5 (AI 1500 ng/day) for NDIPA by Health Canada
|
|
2
|
405
|
June 6, 2024
|
|
Examining the Use of Surrogates in Combination with The Carcinogenic Potency Categorization Approach when Establishing Acceptable Intake Limits of N-Nitrosamine Impurities
|
|
0
|
399
|
June 9, 2024
|
|
Structuring expert review using AOPs: Enabling robust weight-of-evidence assessments for carcinogenicity under ICH S1B(R1)
|
|
0
|
234
|
June 9, 2024
|
|
Nitrosamines limits
|
|
1
|
315
|
June 7, 2024
|
|
Nitrosamines impurities and ICH M7
|
|
1
|
202
|
June 4, 2024
|
|
🇨🇦 Health Canada updated the guidance and Appendix 1(March 15, 2024)
|
|
11
|
2573
|
June 3, 2024
|
|
Visualization of Categorized Compounds by CPCA
|
|
64
|
7624
|
June 1, 2024
|
|
AI limit of API having very law MDD
|
|
1
|
262
|
May 27, 2024
|
|
N-nitrososarcosine limit
|
|
5
|
483
|
May 23, 2024
|
|
:australia: TGA - Latest Update to Nitrosamine Limits
|
|
2
|
861
|
May 23, 2024
|
|
Acceptable intake (AI) of N-Nitroso-N-methylbenzylamine (CAS 937-40-6)
|
|
4
|
301
|
May 21, 2024
|
|
Category 5 NDSRIs- CPCA tool
|
|
2
|
386
|
May 20, 2024
|
|
Hot of the presses - New CPCA paper
|
|
1
|
361
|
May 17, 2024
|
|
EMA Q&A Appendix 1 update posted on Feb. 26, 2024
|
|
28
|
2950
|
May 16, 2024
|
|
Nitrosamine AI limit calculation if the risk is coming only out of excipients'
|
|
11
|
957
|
May 13, 2024
|